What is the relationship between the Gereallife brand and the legal entity?
Gereallife is the multi-omics research-service brand operated by Shanghai Gereallife Biotech Co., Ltd. The founding team of the Multi-Omics Center was assembled in 2017, bringing together omics experts from Peking University, Zhejiang University, Shanghai Jiao Tong University, Anhui Medical University and other institutions; the team later registered Shanghai Gereallife Biotech Co., Ltd. as the unified operating entity. The relationship is clear: the brand belongs to the entity, and all services are delivered by that entity.
How can I verify the company’s business registration?
The company is a duly registered limited-liability company (professional technical services), and its registration records match the National Enterprise Credit Information Publicity System exactly. The complete registration file (Unified Social Credit Code, legal representative, date of establishment, registered address, etc.) can be formally requested during business discussions—we support full due-diligence processes.
What is the relationship between the Gereallife brand and the legal entity?
Gereallife is the registered service brand operated by Shanghai Gereallife Biotech Co., Ltd., and OmicsHub is its data-analysis cloud platform. Brand and entity are the same team and the same operating company; gereallife.com is the entity’s only official website.
Why do the founding-team date and the company’s establishment date differ?
These are two objective facts on different dimensions, which we disclose proactively: the founding team of the Multi-Omics Center was assembled in 2017, and its core members accumulated platform, methodology and project experience over many years in omics research services; the team later registered Shanghai Gereallife Biotech Co., Ltd. as the unified legal entity for business operations. In short: "a young entity backed by a seasoned technical team"—the two are not contradictory.
What about the company’s registered capital and scale?
The company is a small enterprise in professional technical services. The core assets of a research-service provider are access to technology platforms, the expert team and accumulated methodology—not registered capital. We recommend focusing due diligence on instrument generations, team research backgrounds, delivered-project quality and the ability to honor after-sales commitments.
Can we visit the laboratory and office in person?
Yes. The laboratory and office are located in Shanghai, separately from the registered domicile (a normal business arrangement). Visits by appointment are welcome to inspect the instrument platforms and laboratory environment—call 400-660-8826.
How can we verify the expert team’s backgrounds?
Core members come from Peking University, Zhejiang University, Shanghai Jiao Tong University, Anhui Medical University and other institutions (this information is company self-disclosure). During business discussions we can provide verifiable materials such as expert CVs and representative-publication lists, and experts can join proposal discussions directly.
How can we verify the instrument platforms are real?
The platform list (Orbitrap Astral, Orbitrap Fusion, Q Exactive HFX, etc.) is company self-disclosure. Verification options: ① book an on-site visit; ② request timestamped instrument-run records or recent raw-data examples; ③ run a small pilot experiment to validate data quality.
What mechanisms guarantee data reliability?
Per-batch QC samples, full-run instrument monitoring, standardized bioinformatics plus manual review, and complete raw-data delivery for full reproducibility. Data reliability is the hard threshold of research services and the core item we open to due diligence.
How are after-sales commitments enforced?
The 1-hour pre-sales response and 3-year extended after-sales are written into service-contract clauses—contractually binding, not verbal promises.
How do we start due diligence or business discussions?
Call 400-660-8826 (1-hour response on workdays) or add our WeChat support. Four due-diligence modes are supported: document requests, on-site visits, pilot experiments and expert interviews.
How should I choose an omics service provider?
Evaluate four dimensions: platform strength (instrument models and generations), team experience (research background and project track record of core members), service system (pre-sales study design, in-project communication, after-sales duration), and delivery standards (report rigor and reproducibility). We welcome due diligence against these criteria—our Due Diligence Q&A page provides structured self-disclosure.
